T&L Biotechnology
Latest round
- Series A
Last raised
- Mar 2023
Total raised
- $15M
Investors
- 2
About T&L Biotechnology
Based in Beijing, China, and founded in 2011, T&L Biotechnology operates as a cell and gene therapy services provider that provides products and services for life sciences. It has established a 2000? R&D laboratory and clean workshop. It reached a strategic partnership with Youjia Biological to promote nucleic acid drug development. The company engages in provides raw material reagents and services for cell and gene therapy drugs, antibody drug development, cell storage, and other biopharmaceutical and IVD fields. The products can be categorized into humanized antibodies, cytokines, immune magnetic beads, DNA/RNAi reagents, target proteins, and culture media. It also provides technical services including recombinant protein expression development, pilot production and process optimization, cell commissioning service, antibody production, and preparation development.
Who invested in T&L Biotechnology
2 investors across 1 round
See all investors in T&L Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 20, 2023
Amount
$15M
Investors
Questions about T&L Biotechnology
Who invested in T&L Biotechnology?
T&L Biotechnology has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has T&L Biotechnology raised?
T&L Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did T&L Biotechnology last raise money?
T&L Biotechnology's most recent round on record is a Series A, in Mar 2023.
What does T&L Biotechnology do?
Based in Beijing, China, and founded in 2011, T&L Biotechnology operates as a cell and gene therapy services provider that provides products and services for life sciences.
Where is T&L Biotechnology headquartered?
T&L Biotechnology is headquartered in Beijing, China.
Which VCs invest in companies like T&L Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at T&L Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like T&L Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.